Homepage
Medication Guide
Indications for Niraparib
Niraparib (Zejula) is a PARP inhibitor indicated for maintenance treatment of certain patients with ovarian cancer.Indications for Niraparib1. First-line Maintenance Treatment of Advanced Ovarian Canc...
511
Thursday, April 30th, 2026, 09:16
What Are the Common Side Effects of Adagrasib?
Adagrasib is a targeted therapy for KRAS G12C mutations, used as monotherapy for non-small cell lung cancer and in combination with cetuximab for colorectal cancer.What Are the Common Side Effects?1. ...
515
Wednesday, April 29th, 2026, 10:16
Is Adagrasib available in China?
Adagrasib is a novel targeted therapy for the KRAS G12C mutation and has not yet been officially approved for sale in mainland China. Patients needing this drug must obtain it through specific legal c...
524
Wednesday, April 29th, 2026, 10:13
Indications of Azacitidine Tablets
Azacitidine tablets are an oral maintenance therapy. Correctly understanding the indicated population, contraindications, and special population medication rules is a prerequisite for ensuring efficac...
512
Monday, April 27th, 2026, 11:33
Dosage and Administration of Azacitidine Tablets
Azacitidine tablets are a key maintenance therapy drug for acute myeloid leukemia, and standardized medication and health management are equally important.Dosage and Administration of Azacitidine Tabl...
512
Monday, April 27th, 2026, 10:17
Dosage and Administration of Valcyte
Valcyte (valganciclovir) is a prescription antiviral medication. Proper dosage, strict precautions, and a healthy lifestyle are effective measures to ensure efficacy and safety.Dosage and Administrati...
509
Friday, April 24th, 2026, 14:00
Comprehensive Analysis of Valcyte: Side Effects, Relief Measures and Storage Conditions
While Valcyte exerts effective antiviral effects, it also presents significant toxic and side effects.I. Common Side Effects of Valcyte1. Hematological Toxicity(1) It is one of the most severe adverse...
509
Friday, April 24th, 2026, 13:57
Idelalisib (Zydelig): Dosage, Administration, Precautions and Healthy Lifestyle Guidelines
Idelalisib (Zydelig) is an oral PI3Kδ inhibitor indicated for the treatment of relapsed chronic lymphocytic leukemia (CLL).I. Dosage and Administration1. Standard Dosage(1) The recommended dose is 150...
510
Thursday, April 23rd, 2026, 17:24
Side Effects, Mitigation Measures and Storage Guidelines for Idelalisib (Zydelig)
Idelalisib (Zydelig) is an oral PI3Kδ inhibitor indicated for the treatment of relapsed chronic lymphocytic leukemia.I. Common Side Effects of Idelalisib1. Adverse Reactions with Incidence Rate ≥ 30%(...
511
Thursday, April 23rd, 2026, 17:21
Guidelines for Adverse Effect Management and Storage of Capmatinib (Tabrecta)
While effectively inhibiting tumors, capmatinib (Tabrecta) may induce a variety of adverse reactions.I. Common Adverse Effects of Capmatinib1. Adverse effects with an incidence rate ≥ 20%The most freq...
516
Wednesday, April 22nd, 2026, 09:35
14 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved